Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 15(9): 1068-73, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22013730

RESUMO

BACKGROUND AND OBJECTIVES: It is increasingly recognized that a low grade of systemic inflammation occurs in patients with advanced chronic obstructive pulmonary disease (COPD). C-reactive protein (CRP), a marker of systemic chronic inflammatory response, has been related with decreased survival in large cohorts of COPD patients. The aim of the study was to assess if resting dynamic pulmonary hyperinflation (DH) is linked to the presence of systemic inflammation in COPD. MATERIALS AND METHODS: In a 12-month retrospective study involving 55 out-patients with COPD (FEV1 59+/- 23% pred.) examined in stable conditions, inspiratory capacity (IC) was measured at rest and considered as index of DH when lower than 80% predicted. Simultaneously, CRP (by immuno-turbidometry) and white blood cells (WBC), uric acid and alpha-1 globulins were measured in the venous blood in the morning before eating. RESULTS: CRP was significantly increased in the COPD patients with IC < 80% pred. (n = 35; IC = 61 + 14% pred.) as compared with that measured in COPD patients with IC > 80% pred. (n = 20; IC = 97 + 13% pred.), amounting to 0.70 +/- 0.59 vs 0.29 +/- 0.28 mg/dl, respectively (p < 0.01). CRP was inversely related to IC (% pred.) (r = 0.45, p < 0.01). WBC, serum uric acid (an endogenous danger signal), and albumin and alfa-1 globulins were not different between the two groups. DISCUSSION: These results show that the IC reduction is associated with higher serum levels of CRP in stable COPD patients, suggesting a potential role of dynamic pulmonary hyperinflation on development and maintenance of low grade systemic inflammation in COPD.


Assuntos
Inflamação/complicações , Pulmão/fisiopatologia , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Idoso , alfa-Globulinas/metabolismo , Biomarcadores/sangue , Proteína C-Reativa/metabolismo , Distribuição de Qui-Quadrado , Feminino , Volume Expiratório Forçado , Humanos , Inflamação/sangue , Inflamação/imunologia , Mediadores da Inflamação/sangue , Capacidade Inspiratória , Itália , Contagem de Leucócitos , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Doença Pulmonar Obstrutiva Crônica/sangue , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/imunologia , Estudos Retrospectivos , Índice de Gravidade de Doença , Fatores de Tempo , Ácido Úrico/sangue
2.
Acta Diabetol ; 38(1): 27-30, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11487173

RESUMO

The determination of a patient's nutritional condition is an important moment of clinical evaluation in everyday experience. Quite often, it is important to identify symptoms, signs and objective parameters that may reveal a malnourished condition. To satisfy this request, clinicians recur to clinical examination and biochemical tests. It is also possible to use indirect calorimetry. Through the evaluation of oxygen consumption (VO2) and carbon dioxide production (VCO2), indirect calorimetry permits the respiratory quotient (RQ) to be calculated and the exact energy consumption during resting conditions to be determined. This technology, currently used in research departments and in hospital units, is more accurate for the estimation of resting energy expenditure (REE) than the Harris-Benedict equation, especially in the case of patients affected by respiratory diseases or other systemic conditions. The evaluation of REE through indirect calorimetry is a useful monitoring and prognostic index in acutely and chronically ill patients.


Assuntos
Metabolismo Energético , Doenças Respiratórias/metabolismo , Idoso , Calorimetria Indireta , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Consumo de Oxigênio , Doença Pulmonar Obstrutiva Crônica/metabolismo , Descanso
3.
Ann Thorac Surg ; 60(2): 452-4, 1995 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7646119

RESUMO

Cardiomyoplasty recently has been introduced as a surgical therapy for long-lasting cardiac dysfunction in selected patients. We report the case of a patient affected by chronic heart failure, unresponsive to maximal medical therapy, with concomitant posttraumatic injury of the left phrenic nerve, left diaphragm eventration, and cardiac malposition (right displacement). In view of the progressive deterioration of the cardiac function, cardiomyoplasty was recommended, and the right latissimus dorsi muscle was used to perform the wrapping procedure. A 6-month follow-up showed significant functional, as well as hemodynamic, improvements in addition to a reduction in medical therapy.


Assuntos
Cardiomiopatia Dilatada/complicações , Cardiomiopatia Dilatada/cirurgia , Cardiomioplastia , Eventração Diafragmática/cirurgia , Traumatismos Torácicos/complicações , Eventração Diafragmática/etiologia , Eventração Diafragmática/fisiopatologia , Hemodinâmica , Humanos , Masculino , Pessoa de Meia-Idade , Pericárdio/transplante , Nervo Frênico/lesões , Retalhos Cirúrgicos , Traumatismos Torácicos/fisiopatologia , Resultado do Tratamento
4.
Arzneimittelforschung ; 29(8a): 1287-95, 1979.
Artigo em Alemão | MEDLINE | ID: mdl-540074

RESUMO

Many experimental investigations have shown that labyrinthine fluids play a basic role in the physiology of the inner ear. Modifications of perilymphatic fluids have been demonstrated in perceptive deafness (otosclerosis, Ménière's disease, tympanolabyrinthosclerosis). Vasoactive agents fail to markedly affect the exchange between labyrinthine fluids, so that perceptive syndromes are generally regarded as unresponsive to treatment. Several studies have shown the effectiveness of 10-methoxy-1,6-diemthyl-ergoline-8 beta-methanol-(5-bromonicotinate) (nicergoline, Sermion) in various conditions of the inner ear. In this investigation, 30 patients with presbyacusis were treated with 30 mg/day p.o. for 30 days. Speech audiometric curves were improved in 4 out of 18 cases of physiological presbyacusis and in 6 out of 12 cases of accelerated presbyacusis. These results are very interesting, since few effective therapies are available to treat these conditions.


Assuntos
Orelha Interna/fisiopatologia , Ergolinas/uso terapêutico , Perda Auditiva Neurossensorial/tratamento farmacológico , Nicergolina/uso terapêutico , Presbiacusia/tratamento farmacológico , Animais , Gatos , Cobaias , Humanos , Presbiacusia/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...